US 11931402
Compositions for treating heart disease by inhibiting the action of mAKAP-β
granted A61KA61K31/519A61K31/7048
Quick answer
US patent 11931402 (Compositions for treating heart disease by inhibiting the action of mAKAP-β) held by Anchored RSK3 Inhibitors, LLC expires Mon Mar 14 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Anchored RSK3 Inhibitors, LLC
- Grant date
- Tue Mar 19 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Mar 14 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 17
- CPC classes
- A61K, A61K31/519, A61K31/7048, A61K31/713, A61K38/005